151 related articles for article (PubMed ID: 22927063)
1. Near-diploid hyperploidy in early breast cancer (T1a,b) is associated with higher risk of lymph node involvement.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Tomaš-Zekić S; Marinović-Guić M; Tomić S
Pathol Oncol Res; 2013 Jan; 19(1):71-7. PubMed ID: 22927063
[TBL] [Abstract][Full Text] [Related]
2. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
3. Pathobiology of HER 2 positive small invasive (T1a,b) breast cancer: "A wolf in sheep's clothing".
Bezić J; Šamija Projić I; Projić P; Meljanac Salopek K; Živković PM; Božić J; Tomić S
Pathol Res Pract; 2017 Dec; 213(12):1510-1514. PubMed ID: 29033181
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
[TBL] [Abstract][Full Text] [Related]
5. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
[TBL] [Abstract][Full Text] [Related]
6. Effect of DNA ploidy classification on prognosis in breast cancer.
Joensuu H; Alanen K; Falkmer UG; Klemi P; Nordling S; Remvikos Y; Toikkanen S
Int J Cancer; 1992 Nov; 52(5):701-6. PubMed ID: 1428229
[TBL] [Abstract][Full Text] [Related]
7. Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.
Noguchi M; Taniya T; Ohta N; Koyasaki N; Miyazaki I; Mizukami Y
Breast Cancer Res Treat; 1991 Sep; 19(1):23-31. PubMed ID: 1661623
[TBL] [Abstract][Full Text] [Related]
8. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
Prasad AR; Divine G; Zarbo RJ
Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer.
Njølstad TS; Trovik J; Hveem TS; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; ; Amant F; Werner HM; Salvesen HB; Danielsen HE
Br J Cancer; 2015 May; 112(10):1656-64. PubMed ID: 25897678
[TBL] [Abstract][Full Text] [Related]
11. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
[TBL] [Abstract][Full Text] [Related]
12. Node negative breast cancer: the prognostic value of DNA ploidy for long-term survival.
Yuan J; Hennessy C; Corbett IP; Dykin R; Givan AL; Shenton BK; Henry JA; Wright C; Lennard TW
Br J Surg; 1991 Jul; 78(7):844-8. PubMed ID: 1678669
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: clinical and biologic significance.
Kimball RE; Schlaerth JB; Kute TE; Schlaerth AC; Santoso J; Ballon SC; Spirtos NM
Am J Obstet Gynecol; 1997 Jun; 176(6):1319-26; discussion 1326-7. PubMed ID: 9215191
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer.
Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
Int J Clin Oncol; 2001 Aug; 6(4):177-82. PubMed ID: 11706555
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of flow cytometric DNA analysis in metastatic lymph node of colorectal cancer].
Ando Y; Tsuchiya A; Katagata N; Kanazawa M; Watanabe F; Sato H; Kikuchi Y; Yoshida T; Abe R
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():41-6. PubMed ID: 8203929
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients.
Beerman H; Kluin PM; Hermans J; van de Velde CJ; Cornelisse CJ
Int J Cancer; 1990 Jan; 45(1):34-9. PubMed ID: 2298504
[TBL] [Abstract][Full Text] [Related]
18. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
Friedman NS; Freedman MD
Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
[TBL] [Abstract][Full Text] [Related]
19. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
Winter K; Eidtmann H; Jonat W
Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
[TBL] [Abstract][Full Text] [Related]
20. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
